organization
| Coefficient Giving | $12,019,799 | 100% | 4 |
| Greg Lanzaro | $11,748,967 | 98% | 2 |
| Koen Van Rompay | $170,190 | 1% | 1 |
| Lark L. Coffey | $100,642 | 1% | 1 |
| Date ↓ | Funder | Via | Amount | Cause | Source | Purpose |
|---|---|---|---|---|---|---|
| Jun 2026 | Coefficient Giving | $710,344 | Biosecurity | coefficient_giving | Field Testing of Building Protections from Airborne Hazards | |
| Nov 2025 | Coefficient Giving | $3,150,275 | Global health and development | coefficient_giving | Antimalarial Gene Drive Research | |
| Oct 2025 | Coefficient Giving | $2,660,838 | Global health and development | coefficient_giving | Antimalarial Gene Drive Research | |
| Apr 2024 | Coefficient Giving | $500,000 | Global health and development | coefficient_giving | Insectary for Malaria Gene Drive Research |
| Date ↓ | Funder | Recipient | Via | Amount | Cause | Source | Purpose |
|---|---|---|---|---|---|---|---|
| Dec 2021 | Coefficient Giving | Greg Lanzaro | University of California, Davis | $10,248,967 | Global health and development | coefficient_giving | Malaria Gene Drive Feasibility Analysis (Greg Lanzaro) |
| Mar 2021 | Coefficient Giving | Lark L. Coffey | University of California, Davis | $100,642 | Global health and development | coefficient_giving | COVID-19 Antiviral Studies (Lark L. Coffey) |
| Mar 2020 | Coefficient Giving | Koen Van Rompay | University of California, Davis | $170,190 | Global health and development | coefficient_giving | Research on Antiviral Drugs (Koen Van Rompay) |
| Feb 2020 | Coefficient Giving | Greg Lanzaro | University of California, Davis | $1,500,000 | Global health and development | coefficient_giving | Malaria Gene Drive Feasibility Analysis (Greg Lanzaro) |